Literature DB >> 27656569

Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.

Divya Gopinath1, Beena Valappil Thannikunnath2, Salmanul Faris Neermunda3.   

Abstract

INTRODUCTION: Oral Leukoplakia (OL), the most common potentially malignant disorder, is diagnosed clinically on the basis of exclusion of other lesions. In a country like India, where prevalence of oral cancer is very high, the issue of carcinomatous foci within OL at the time of initial diagnosis of leukoplakia has never been addressed before. AIM: To estimate the prevalence and risk factors for epithelial dysplasia as well as carcinoma within OL lesions at the time of initial clinical presentation in an Indian population with high prevalence of tobacco use.
MATERIALS AND METHODS: Clinical and pathologic data (age, sex, lesion location and histopathologic grading) of 546 cases of leukoplakia were analyzed. The prevalence rate of dysplasia and carcinoma in 546 oral leukoplakia cases was calculated. Univariate analysis was performed to examine risk factors associated with the presence of carcinoma and dysplasia within the lesions.
RESULTS: The male to female ratio in this study was 2:1. Majority of the patients irrespective of sex had a history of tobacco use. Of the total 85% of non-homogeneous lesions and 70% for the homogeneous lesions were illustrating, features of epithelial dysplasia. The prevalence rate of carcinoma was 11.9%. In univariate analysis it was found that lesion site, clinical appearance, tobacco use were strongly correlated with the presence of carcinoma within OL.
CONCLUSION: Our results demonstrate that majority of leukoplakia irrespective of its clinical appearance contain a dysplastic component and significant proportion contains carcinomatous foci. Lesions with certain features are more prone to have carcinomatous foci. However there is always a chance of finding foci of carcinoma in OL anywhere in the oral cavity. Therefore, excision biopsy is always mandatory before long term follow-up and treatment is planned.

Entities:  

Keywords:  Leukoplakia turning malignant; Potentially malignant disorders; Premalignant lesions

Year:  2016        PMID: 27656569      PMCID: PMC5028553          DOI: 10.7860/JCDR/2016/16815.8305

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India.

Authors:  S Silverman; K Bhargava; L W Smith; A M Malaowalla
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

2.  Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial.

Authors:  Rengaswamy Sankaranarayanan; Kunnambath Ramadas; Gigi Thomas; Richard Muwonge; Somanathan Thara; Babu Mathew; Balakrishnan Rajan
Journal:  Lancet       Date:  2005 Jun 4-10       Impact factor: 79.321

3.  Oral verrucous lesions: Controversies in diagnosis and management.

Authors:  D Mehrotra; M Goel; S Kumar; R Pandey; Hari Ram
Journal:  J Oral Biol Craniofac Res       Date:  2012-10-18

4.  Oral tongue cancer in young patients: a matched analysis.

Authors:  Werner Garavello; Roberto Spreafico; Renato Maria Gaini
Journal:  Oral Oncol       Date:  2007-02-16       Impact factor: 5.337

5.  Tobacco use in India: prevalence and predictors of smoking and chewing in a national cross sectional household survey.

Authors:  M Rani; S Bonu; P Jha; S N Nguyen; L Jamjoum
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

6.  Follow-up of oral leukoplakia after carbon dioxide laser surgery.

Authors:  F Chiesa; N Tradati; L Sala; L Costa; S Podrecca; P Boracchi; G Bandieramonte; M Mauri; R Molinari
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-02

7.  Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.

Authors:  Jang-Jaer Lee; Hsin-Chia Hung; Shi-Jung Cheng; Yi-Jane Chen; Chun-Pin Chiang; Bu-Yuan Liu; Jiiang-Huei Jeng; Hao-Hueng Chang; Ying-Shiung Kuo; Wan-Hong Lan; Sang-Heng Kok
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-01-19

8.  Oral epithelial dysplasia: clinical characteristics of western European residents.

Authors:  M A Jaber; S R Porter; P Speight; J W Eveson; C Scully
Journal:  Oral Oncol       Date:  2003-09       Impact factor: 5.337

9.  Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy.

Authors:  M Pentenero; M Carrozzo; M Pagano; D Galliano; R Broccoletti; C Scully; S Gandolfo
Journal:  Oral Dis       Date:  2003-03       Impact factor: 3.511

10.  Surgical treatment of premalignant lesions of the oral mucosa.

Authors:  P Vedtofte; P Holmstrup; E Hjørting-Hansen; J J Pindborg
Journal:  Int J Oral Maxillofac Surg       Date:  1987-12       Impact factor: 2.789

View more
  5 in total

1.  Analysis of Oral Leukoplakia and Tobacco-Related Habits in Population of Chengalpattu District- An Institution-Based Retrospective Study.

Authors:  Aarthi Venkat; Sathya Kumar M; Aravindhan R; Magesh K T; Sivachandran A
Journal:  Cureus       Date:  2022-06-14

2.  Role of nano curcumin on superoxide dismutase levels in leukoplakia.

Authors:  Sunanda Deb; Deepak Bhargava; Puja Bansal; Vijay Kanuru
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

3.  Oral leukoplakia in the Sudan: clinicopathological features and risk factors.

Authors:  Mayson B Mustafa; Mohammed O Hassan; Abdelazeem Alhussein; Eltahir Mamoun; Mariam El Sheikh; Ahmed M Suleiman
Journal:  Int Dent J       Date:  2019-08-12       Impact factor: 2.607

4.  Oral Potentially Malignant Disorders and Squamous Cell Carcinoma at the Tongue: Clinicopathological Analysis in a Thai Population.

Authors:  Anchisa Aittiwarapoj; Rachai Juengsomjit; Nakarin Kitkumthorn; Puangwan Lapthanasupkul
Journal:  Eur J Dent       Date:  2019-10-16

5.  A standalone approach to utilize telomere length measurement as a surveillance tool in oral leukoplakia.

Authors:  Jagannath Pal; Yogita Rajput; Shruti Shrivastava; Renuka Gahine; Varsha Mungutwar; Tripti Barardiya; Ankur Chandrakar; Pinaka Pani Ramakrishna; Sovna Shivani Mishra; Hansa Banjara; Vivek Choudhary; Pradeep K Patra; Masood A Shammas
Journal:  Mol Oncol       Date:  2022-01-07       Impact factor: 7.449

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.